氙制药 XENE
$39.17 +$1.49 (+3.95%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $39.39 +0.56%
开盘$37.80
昨收$37.68
当日区间$37.15 – $39.21
成交量869.7K
市值$3.79B
市盈率（TTM）–
股息率–
财报
财报日平均波动±5.1%近16次财报
收涨次数4 / 1625% 的概率
最佳反应+8.3%
最差反应-17.4%
每次财报后次日股价变动
| 季度 | 财报日期 | 时段 | 隐含波动 | 实际波动 | 较隐含波动 |
|---|---|---|---|---|---|
| 2026/Q2 | 6 Aug 2026 | After Market | ±8.8% | -1.84% | 符合区间 |
| 2026/Q1 | 7 May 2026 | After Market | ±10.1% | +0.79% | 符合区间 |
| 2025/Q3 | 3 Nov 2025 | After Market | ±11.0% | -4.94% | 符合区间 |
| 2025/Q2 | 11 Aug 2025 | After Market | ±9.9% | +5.51% | 符合区间 |
| 2025/Q1 | 12 May 2025 | After Market | ±9.8% | -17.43% | 超出定价预期 |
| 2024/Q4 | 27 Feb 2025 | After Market | ±21.3% | -3.37% | 符合区间 |
| 2024/Q3 | 12 Nov 2024 | After Market | ±9.7% | -3.27% | 符合区间 |
| 2024/Q2 | 8 Aug 2024 | After Market | – | -3.19% | – |
| 2024/Q1 | 9 May 2024 | After Market | ±11.3% | -4.59% | 符合区间 |
| 2023/Q4 | 29 Feb 2024 | After Market | ±11.5% | -0.76% | 符合区间 |
| 2023/Q3 | 8 Nov 2023 | After Market | ±12.8% | -6.69% | 符合区间 |
| 2023/Q2 | 9 Aug 2023 | After Market | ±11.8% | +8.29% | 符合区间 |
| 2023/Q1 | 9 May 2023 | After Market | ±12.3% | -5.51% | 符合区间 |
| 2022/Q4 | 1 Mar 2023 | After Market | ±12.8% | -7.39% | 符合区间 |
| 2022/Q3 | 8 Nov 2022 | After Market | ±17.2% | -6.61% | 符合区间 |
| 2022/Q2 | 9 Aug 2022 | After Market | ±10.9% | +0.84% | 符合区间 |
"隐含波动"指财报发布前期权市场定价的预期波幅。"波动"指财报发布后首个交易日的股价变化。
基本面
最新报告季度：Q2, ended Jun 2026
营收$0.00
营业利润-$123.16M-30.7% YoY
净利润-$110.74M-30.7% YoY
摊薄每股收益-$1.11-3.7% YoY
自由现金流-$95.67M-48.6% YoY
经营现金流-$95.39M
营收，近8个季度
净利润，近8个季度
盈利能力与资产负债表
净资产收益率-43.6%
资产收益率-41.5%
投入资本回报率-46.5%
流动比率21.02
负债/资产比率4.1%
现金及投资$930.69M
总负债$5.08M
净现金（净负债）$925.61M
暂无评论——快来第一个聊聊 XENE。
登录后参与讨论。